Global AFP Testing Market to Benefit from Rising Incidence of Cancers

A new report from Transparency Market Research, titled ‘AFP Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,’ states that the global market is expected to expand swiftly over the forecast period. The market’s growth will result from the rising cancer incidence and the increasing efforts taken by researchers to discover new techniques to introduce AFP testing.

Alpha-fetoprotein (AFP) is a very commonly found plasma protein in the human fetus. The AFP protein found in the human fetus is encoded by the alpha-fetoprotein gene, located on chromosome 4. The AFP plasma protein is produced at the time of fetal development in the liver and yolk sac. AFP, a glycoprotein, is found in dimeric, monomeric, and trimeric forms. Alpha-fetoprotein is produced in the fetus by immature liver cells and thus, infants have high levels of AFP. A low level of alpha-fetoprotein is found in pregnant women and also in the blood of healthy adults. Biochemical tests are performed to evaluate the levels of AFP protein in pregnant women’s blood. The detection of a low or high level of AFP in women’s blood helps doctors to identify the chances of birth defects or any other problems. AFP-based tests help to determine various chromosomal aberrations such as Edward’s syndrome, Down’s syndrome, neural tube defects, and particular types of cancer.

Over the past few years, AFP screening tests have been widely used. A lot of these are commercially available considering their sensitivity in the diagnosis of cancer. Under normal circumstances, the level of AFP in the human body is not more than 10ng/ml. The level can soar up to 500ng/ml in people suffering from chronic hepatitis. A high level of AFP is also recorded in patients suffering from Hodgkin’s disease, brain tumors, lymphoma, and renal cancer. The cancer diagnostic segment is rapidly growing as researchers are focusing on discovering antigen and new techniques to enhance the treatments. Thus, the global AFP testing market is expected to expand in the years to come.

View exclusive Global strategic Business report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1623

The geriatric population is more prone to tumor development and diseases. Thus, the rising geriatric population is another important factor expected to drive the global AFP testing market in the years to come. The global AFP testing market is widespread with leading players covering major geographical locations. By geography, the global AFP testing market is divided into Asia Pacific, Europe, North America, and Rest of the World.

Abbott Laboratories, Bio-Rad Laboratories, Kreatech Diagnostics, Biomedical Diagnostics, Beckman Coulter, and Roche Diagnostics are some of the prominent players operating in the global AFP testing market. The introduction of new AFP testing methods by leading players is expected to contribute towards the growth of the global AFP testing market in the near future.

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.